Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

MoonLake Immunotherapeutics (MLTX) Short Interest Ratio & Short Volume

MoonLake Immunotherapeutics logo
$16.41 -0.03 (-0.16%)
As of 11:17 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

MoonLake Immunotherapeutics Short Interest Overview

As of April 30, 2026, MoonLake Immunotherapeutics (MLTX) had a short interest of 6.32 million shares sold short, representing 10.02% of the public float. This marks a -5.02% decrease in short interest since the prior report. The short interest ratio (days to cover) is 9.3, meaning it would take 9.3 days of the average trading volume of 1.65 million shares to cover all short positions.

Current Short Interest
6,320,177 shares
Previous Short Interest
6,654,522 shares
Change Vs. Previous Month
-5.02%
Dollar Volume Sold Short
$103.52 million
Short Interest Ratio
9.3 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
71,728,000 shares
Short Percent of Float
10.02%
Today's Trading Volume
397,849 shares
Average Trading Volume
1,654,565 shares
Today's Volume Vs. Average
24%
Short Selling MoonLake Immunotherapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for MoonLake Immunotherapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

MLTX Short Interest Over Time

MLTX Days to Cover Over Time

MLTX Percentage of Float Shorted Over Time

MoonLake Immunotherapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20266,320,177 shares $103.52 million -5.0%10.0%9.25 $16.38
4/15/20266,654,522 shares $119.91 million -14.2%10.5%4.24 $18.02
3/31/20267,757,169 shares $144.59 million +6.1%12.3%7.78 $18.64
3/13/20267,313,594 shares $125.28 million +3.9%11.6%9.14 $17.13
2/27/20267,036,421 shares $123.21 million -3.2%11.2%4.38 $17.51
2/13/20267,271,326 shares $114.67 million +3.6%12.9%6.91 $15.77
1/30/20267,017,037 shares $109.96 million -2.3%12.4%4.96 $15.67
1/15/20267,182,036 shares $117.43 million +24.3%12.7%1.28 $16.35
12/31/20255,776,842 shares $76.14 million +18.0%10.2%4.94 $13.18
12/15/20254,894,840 shares $70.09 million +14.6%8.7%2.45 $14.32
11/28/20254,270,493 shares $59.02 million +10.7%7.6%2.16 $13.82
11/14/20253,856,500 shares $49.25 million -21.4%6.8%1.65 $12.77
10/31/20254,907,886 shares $49.57 million +0.4%8.7%1.77 $10.10
10/15/20254,890,000 shares $48.36 million -15.3%8.9%1.2 $9.89
9/30/20255,770,000 shares $41.37 million +16.6%10.5%1.6 $7.17
9/15/20254,950,000 shares $263.69 million -4.4%9.0%8.7 $53.27
8/31/20255,180,000 shares $288.79 million -3.5%9.4%10.2 $55.75
8/15/20255,370,000 shares $292.07 million -12.4%9.7%10 $54.39
7/31/20256,130,000 shares $309.20 million -3.3%11.0%11.6 $50.44
7/15/20256,340,000 shares $314.91 million +4.5%12.0%12.3 $49.67
6/30/20256,070,000 shares $286.50 million -0.8%11.5%11.8 $47.20
6/15/20256,120,000 shares $270.57 million -3.0%11.6%11.9 $44.21
5/31/20256,310,000 shares $246.47 million +4.5%11.9%11.9 $39.06
5/15/20256,040,000 shares $227.47 million -1.0%11.4%14 $37.66
4/30/20256,100,000 shares $256.69 million -8.0%11.5%14.3 $42.08
4/15/20256,630,000 shares $243.79 million +4.4%12.5%16.1 $36.77
3/31/20256,350,000 shares $248.09 million -12.3%12.0%13.8 $39.07
3/15/20257,240,000 shares $279.10 million -2.7%13.7%18.2 $38.55
2/28/20257,440,000 shares $310.69 million -7.6%14.1%21.4 $41.76
2/15/20258,050,000 shares $347.84 million +4.8%15.3%24.2 $43.21
1/31/20257,680,000 shares $353.20 million -1.5%14.6%24.2 $45.99
1/15/20257,800,000 shares $342.97 million -3.5%14.8%26 $43.97
12/31/20248,080,000 shares $437.53 million +0.5%15.3%32.2 $54.15
12/15/20248,040,000 shares $412.77 million +0.5%15.2%29 $51.34
11/30/20248,000,000 shares $435.44 million No Change15.2%26.6 $54.43
11/15/20248,000,000 shares $390.64 million -0.7%15.2%26.1 $48.83
10/31/20248,060,000 shares $374.15 million -1.1%15.3%26.7 $46.42
10/15/20248,150,000 shares $391.20 million +2.3%15.5%25.4 $48.00
9/30/20247,970,000 shares $401.85 million +2.6%15.2%22.3 $50.42
9/15/20247,770,000 shares $397.36 million -2.1%14.8%23.8 $51.14
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

See the 5 stocks to avoid
8/31/20247,940,000 shares $371.51 million +2.3%15.1%25.2 $46.79
8/15/20247,760,000 shares $372.79 million -0.1%14.8%22.7 $48.04
7/31/20247,770,000 shares $323.62 million -1.8%14.8%21.5 $41.65
7/15/20247,910,000 shares $386.80 million +1.0%15.1%22.6 $48.90
6/30/20247,830,000 shares $344.29 million +0.1%14.9%23.3 $43.97
6/15/20247,820,000 shares $323.83 million -0.8%14.9%22.1 $41.41
5/31/20247,880,000 shares $320.40 million +8.2%15.0%20.2 $40.66
5/15/20247,280,000 shares $296.22 million +5.1%14.0%16.3 $40.69
4/30/20246,930,000 shares $283.51 million -4.6%14.0%15 $40.91
4/15/20247,260,000 shares $316.83 million -5.1%15.4%15.4 $43.64
3/31/20247,650,000 shares $384.26 million +9.3%16.2%15.9 $50.23
3/15/20247,000,000 shares $330.75 million +0.9%14.8%14.8 $47.25
2/29/20246,940,000 shares $334.79 million +5.0%14.7%14.5 $48.24
2/15/20246,610,000 shares $396.80 million -0.9%14.1%13.3 $60.03
1/31/20246,670,000 shares $372.72 million -3.2%14.5%12.2 $55.88
1/15/20246,890,000 shares $401.69 million -0.3%15.0%10.4 $58.30
12/31/20236,910,000 shares $417.29 million -8.0%15.0%9.6 $60.39
12/15/20237,510,000 shares $455.48 million -4.1%16.3%10.4 $60.65
11/30/20237,830,000 shares $343.82 million +7.0%17.7%10.9 $43.91
11/15/20237,320,000 shares $287.38 million +10.2%16.6%10.6 $39.26
10/31/20236,640,000 shares $344.02 million -6.4%16.7%10.4 $51.81
10/15/20237,090,000 shares $387.61 million +3.5%19.7%13.8 $54.67
9/30/20236,850,000 shares $390.45 million +4.1%19.0%14.1 $57.00
9/15/20236,580,000 shares $369.93 million -1.2%15.6%8.7 $56.22
8/31/20236,660,000 shares $383.42 million -10.1%16.8%9.1 $57.57
8/15/20237,410,000 shares $417.03 million +10.6%18.7%10.1 $56.28
7/31/20236,700,000 shares $407.43 million +1.8%16.8%9.2 $60.81
7/15/20236,580,000 shares $357.10 million +6.8%15.2%8.9 $54.27
6/30/20236,160,000 shares $314.16 million +33.9%17.2%8.8 $51.00
6/15/20234,600,000 shares $125.12 million +12.5%13.9%8.5 $27.20
5/31/20234,090,000 shares $111.29 million -5.3%12.8%10.5 $27.21
5/15/20234,320,000 shares $115.60 million +30.1%13.6%12.2 $26.76
4/30/20233,320,000 shares $70.72 million +78.5%12.0%11 $21.30
4/15/20231,860,000 shares $35.41 million +0.5%6.7%6.9 $19.04
3/31/20231,850,000 shares $39.57 million +119.4%6.5%9.1 $21.39
3/15/2023843,300 shares $17.13 million -4.5%2.7%4.7 $20.31
2/28/2023883,400 shares $16.95 million +44.4%2.8%6.9 $19.19
2/15/2023611,800 shares $10.27 million -0.1%1.9%6 $16.79
1/31/2023612,600 shares $7.32 million -0.8%1.9%7.6 $11.95
1/15/2023617,300 shares $7.34 million +0.7%1.9%8.8 $11.89
12/30/2022612,800 shares $6.43 million -14.7%1.9%10.1 $10.50
12/15/2022718,100 shares $6.75 million -15.1%2.3%12.5 $9.40
11/30/2022845,400 shares $8.39 million +38.1%2.7%18.9 $9.93
11/15/2022612,200 shares $5.48 million +0.8%2.0%14.5 $8.95
10/31/2022607,100 shares $5.00 million +1.0%2.0%13.3 $8.24
10/15/2022601,400 shares $5.29 million +0.7%2.0%11 $8.80
9/30/2022597,000 shares $4.63 million +2.5%2.0%10.3 $7.76
9/15/2022582,300 shares $4.48 million +1.5%2.0%11.7 $7.69
8/31/2022573,900 shares $4.63 million -3.4%1.9%9.7 $8.06
8/15/2022594,100 shares $4.24 million -7.2%1.8%6.8 $7.13
SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)

Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel

See how to get positioned in SpaceX before the announcement goes public
7/31/2022640,100 shares $4.03 million +6.5%1.9%7.7 $6.30
7/15/2022601,300 shares $3.53 million No Change1.8%6.6 $5.87

MLTX Short Interest - Frequently Asked Questions

Short interest is the volume of MoonLake Immunotherapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 6,320,177 shares of MLTX short. 10.02% of MoonLake Immunotherapeutics' shares are currently sold short. Learn More on MoonLake Immunotherapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MLTX shares currently have a short interest ratio of 9.3. Learn More on MoonLake Immunotherapeutics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MoonLake Immunotherapeutics: Ikarian Capital LLC, Tudor Investment Corp ET AL, Caption Management LLC, Boothbay Fund Management LLC, and 683 Capital Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.02% of MoonLake Immunotherapeutics' floating shares are currently sold short.

MoonLake Immunotherapeutics saw a decrease in short interest in April. As of April 30th, there was short interest totaling 6,320,177 shares, a decrease of 5.0% from the previous total of 6,654,522 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

10.02% of MoonLake Immunotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MoonLake Immunotherapeutics: Apellis Pharmaceuticals, Inc. (9.01%), Grifols, S.A. (0.83%), CRISPR Therapeutics AG (24.31%), Apogee Therapeutics Inc. (20.27%), Legend Biotech Corporation Sponsored ADR (9.19%), Dianthus Therapeutics, Inc. (12.36%), Indivior PLC (10.60%), NewAmsterdam Pharma Company N.V. (7.86%), Kiniksa Pharmaceuticals International, plc (9.86%), Travere Therapeutics, Inc. (16.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling MLTX is an investing strategy that aims to generate trading profit from MoonLake Immunotherapeutics as its price is falling. MLTX shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for MoonLake Immunotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MLTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MLTX, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like MLTX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:MLTX) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel